Teva Pharmaceuticals TEVA announced a funding agreement with Royalty Pharma plc RPRX, under which the latter will provide up ...

Q1 2026 Management View Mark Harding, President and CEO, opened the call highlighting a "great start to the year" and ...

Incredibuild has acquired Garden to bolster its acceleration capabilities for the entire DevOps lifecycle for game devs and other software makers. Incredibuild said ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva’s anti-IL-15 candidate, ...

Caterpillar (CAT) has expanded its partnership with NVIDIA to accelerate the development of AI-enabled solutions across its ...

Intel Corp. is pushing for more developers to start coding for the next generation of “AI PCs,” launching a new AI Acceleration program for developers, it said today. The chipmaker first delivered its ...

In the coming years, generative AI (GenAI) is expected to revolutionize software product engineering. Because it presents a significant opportunity to enhance software development, drive digital ...

Patient care is changing in the United States right before our eyes and technology innovation is driving that transformation. What kinds of technology? Some familiar examples include engaging patients ...

Global harmonization of CMC guidelines is a key focus for top pharmaceutical consultants. Variations in regulatory requirements across regions often create inefficiencies in drug development—for ...

The promotions of Jamoree Murphy and Isaiah Zukasky to Assistant Management roles reflect Accelerated Management’s strategic ...